Beta Bionics Inc expected to post a loss of 48 cents a share - Earnings Preview

Beta Bionics

02/05/2025 23:48

Beta Bionics Inc BBNX.OQ BBNX.O is expected to report resultson May 6 for the period ending March 31 2025

The Irvine California-based  company is expected to report revenue of $16.151 million, according to the mean estimate from 7 analysts, based on LSEG data.

​LSEG's mean analyst estimate for Beta Bionics Inc is for a loss of 48 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

The average consensus recommendation for the advanced medical equipment & technology peer group is also "Buy".​

Wall Street's median 12-month price target for Beta Bionics Inc is $26.00​, above​ its last closing price of $11.14. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Dec. 31 2024
-0.47
-0.47
-2.72
Missed
-481.8
2024
​
​​
​

This summary was machine generated May 2 at 22:48 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)